CareSens Air CGM

Continuous monitoring.
Consistent value.

CareSens Air: The device you need. The outcomes you deserve.
CareSens Air is a user-friendly Continuous Glucose Monitoring (CGM) system designed to simplify diabetes management. It is a 15-day wear device that delivers real-time readings directly to your smartphone. With a clinically approved sensor1 and a cost-effective price point, it provides a reliable solution without the legacy fee of traditional brands.

Most CGMs focus on the device; some focus  on the price. CareSens Air does both and then we go further.

More than a device. A complete  CGM service.
CareSens Air is a small, lightweight, and clinically proven sensor, but we don’t just hand you the device and walk away. We provide a full clinical support service – from onboarding to weekly follow-ups – acting as an extra pair of hands to ensure the technology actually delivers the outcomes you expect.

CareSens Air with iPhone

Product details

Sensor: Clinically proven
All in one CGM device, 15-day wear, continuously monitoring glucose levels.

  • Reliable 15-day monitoring: 15 days of continuous wear with an 8.7% MARD2 for accurate, real-time glucose trends.
  • Easy to use – Pre-assembled all-in-one device for easy application and a quick 30-minute warm-up time.
  • Slim and light sensor – Ergonomically designed to be thin (0.3mm) and lightweight (4.5g) to minimise discomfort.
  • Built for an active lifestyle: Water-resistant and includes durable adhesive tape to ensure the sensor stays secure during daily activities.
CareSens Air App

CareSens Air App: Master your data
A comprehensive platform designed to help users turn glucose numbers into clear, actionable insights.

  • Real-time glucose monitoring: Visualise glucose trends and statistics in real-time, allowing users to see exactly how their levels change over time.
  • Personalised alerts: Set custom thresholds for low, high, and rapidly changing levels, providing a clinical safety net that keeps users in total control.
  • Activity & lifestyle tracking: Track activities and daily habits to understand the impact on users glucose levels, empowering them to make data-driven decisions for better management.
Sens365 App and Web

Sens365: Shared insights for smarter care
A dedicated web and app platform for carers and healthcare professionals to remotely monitor glucose levels and provide a clinical safety net.

  • Comprehensive glucose management: Access detailed reports and trend tracking to stay connected with patients and monitor outcomes effectively.
  • Data-driven insights: Analyse key metrics and daily events, such as meals and activity, to identify patterns and optimise glycaemic control.
  • Real-time remote monitoring: Access live glucose data to provide immediate support and share insights that empower patients to act on their results.
Customer support

Your diabetes support service: An extra pair of hands
Our support goes beyond basic troubleshooting; we provide a clinical safety net that ensures both you and your patients get the most out of the technology.

  • Hands-on onboarding: We support users with direct training and education on how to use CareSens Air as well as setting up primary care systems.
  • 12 weeks of clinical support: Our expert clinical team provides a safety net by reviewing patients’ glucose data weekly and empowering patients to act on results to improve glycaemic control and quality of life.
  • Education that empowers: Both you and your patients get instant access to award-winning education3 proven to deliver a reduction in HbA1c4.
  • 24/7 human support: Real people are available around the clock to handle patient troubleshooting and how-to questions.

Discover CareSens Air

Healthcare Professionals, book your introductory session today and learn more about CareSens Air

Find out more

Ordering information

ProductQtyPricePIP Code
CareSens Air CGM1£31.87428-3347

At Spirit, we provide affordable diabetes products designed to make management accessible for everyone. Our range is cost-effective without compromising on quality, ensuring every device is reliable, user-friendly, and meets the latest ISO and CE Mark standards.

As part of this commitment, CareSens Air offers a clinically approved, cost-effective option on the Drug Tariff where the savings always stack up. We prioritise the right fit over volume; if a patient is better suited to a different CGM or blood glucose monitor, we’ll suggest it. No ego, just better care

Resources

We have resources and a 24/7 customer support service for you and your patients: user guides, videos, training materials, support team.

View our resources

Cost calculator

Curious about the straightforward value for your region? Try our cost calculator, designed to showcase the money-saving potential across our diabetes range.

This overview highlights savings across our clinically approved and easy-to-implement products. Beyond the calculator, we can delve into your specific prescribing data to identify where our extra pair of hands support can deliver both financial savings and improved patient outcomes.

And remember, the savings always stack up – contact us to find out more.

How much could you save?

1
2

Based on ICB prescribing data from Aug 2024 – Sept 2025 with a 70% switch from current prescribing to comparable products from Spirit Health.

Additional diabetes products

Get in touch today

Please complete the contact form with your enquiry, or if you’d like us to reach out for an introductory chat.


1 Eichenlaub M, Jendrike N, Pleus S, Freckmann G. Accuracy of the 15-Day CareSens Air Continuous Glucose Monitoring System with Optional Calibrations. Institut für Diabetes-Technologie (IDT), University of Ulm, Germany.

2 Spirit Healthcare Group. Data on file: Based on PMCF study in adults with diabetes. 2024.

3 Spirit Healthcare Group. Winner, Clinical Services – Healthcare Outcomes, LaingBuisson Awards 2017.

4 Sutton D et al. Structured Diabetes Education: virtual access was as effective as face-to-face access to a structured diabetes education programme (EMPOWER T2n) in England. medRxiv (preprint). 2024; doi: 10.1101/2024.02.27.24303369.